Kirschner, Matthias
Hager, Oliver M
Bischof, Martin
Hartmann-Riemer, Matthias N
Kluge, Agne
Seifritz, Erich
Tobler, Philippe N
Kaiser, Stefan
Article History
Received: 4 April 2016
Revised: 8 May 2016
Accepted: 10 May 2016
First Online: 15 June 2016
Competing interests
: S.K. has received speaker honoraria from Roche, Lundbeck, Janssen, and Takeda. He receives royalties for cognitive test and training software from Schuhfried. E.S. has received grant support from H. Lundbeck and has served as a consultant and/or speaker for AstraZeneca, Otsuka, Takeda, Eli Lilly, Janssen, Lundbeck, Novartis, Pfizer, Roche, and Servier. P.N.T. has received grant support from Pfizer. None of these activities is related to the present study. The remaining authors declare no conflict of interest.